Literature DB >> 26239302

Changes in Cerebellar Activation After Onabotulinumtoxin A Injections for Spasticity After Chronic Stroke: A Pilot Functional Magnetic Resonance Imaging Study.

Chia-Lin Chang1, Douglas J Weber2, Michael C Munin3.   

Abstract

OBJECTIVE: To investigate the effect of reducing spasticity via onabotulinumtoxin A (Obtx-A) injection on cerebellar activation after chronic stroke during unilateral gripping.
DESIGN: Pre-post, case series.
SETTING: Outpatient spasticity clinic. PARTICIPANTS: Individuals with chronic spasticity (N=4).
INTERVENTIONS: Upper-limb Obtx-A injection. MAIN OUTCOME MEASURES: Functional magnetic resonance imaging (fMRI) was used to measure changes in cerebellar activation before and after upper-limb Obtx-A injection. During fMRI testing, participants performed the same motor task before and after injection, which was 15% and 30% of maximum voluntary isometric gripping measured before Obtx-A injection.
RESULTS: After Obtx-A injection, cerebellar activation increased bilaterally during gripping with the paretic hand and during rest. During both pre- and postinjection scans, the paretic hand showed larger cerebellar activation during gripping compared with the nonparetic hand. Cerebellar activation during gripping with the nonparetic hand did not change significantly after Obtx-A injection.
CONCLUSIONS: Reducing spasticity via Obtx-A injection may increase cerebellar activation both during gripping tasks with the paretic hand and during rest. To our knowledge, this is the first study that examines changes in cerebellar activation after spasticity treatment with Obtx-A.
Copyright © 2015 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Botulinum toxins, type A; Cerebellum; Magnetic resonance imaging; Muscle spasticity; Rehabilitation; Stroke

Mesh:

Substances:

Year:  2015        PMID: 26239302      PMCID: PMC4628596          DOI: 10.1016/j.apmr.2015.07.007

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  58 in total

1.  Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.

Authors:  Zuzana Senkárová; Petr Hlustík; Pavel Otruba; Roman Herzig; Petr Kanovský
Journal:  J Neuroimaging       Date:  2009-05-19       Impact factor: 2.486

2.  Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

Authors:  D M Simpson; D N Alexander; C F O'Brien; M Tagliati; A S Aswad; J M Leon; J Gibson; J M Mordaunt; E P Monaghan
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

3.  Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.

Authors:  R L Rosales; K Arimura; S Takenaga; M Osame
Journal:  Muscle Nerve       Date:  1996-04       Impact factor: 3.217

4.  Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exercise-induced paroxysmal dystonia.

Authors:  A Kluge; B Kettner; R Zschenderlein; D Sandrock; D L Munz; S Hesse; H Meierkord
Journal:  Mov Disord       Date:  1998-01       Impact factor: 10.338

5.  Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from FMRI.

Authors:  Karin Diserens; Dieter Ruegg; Raimund Kleiser; Sandrine Hyde; Nicolas Perret; Philippe Vuadens; Eleonora Fornari; Francois Vingerhoets; Rüdiger J Seitz
Journal:  Neurorehabil Neural Repair       Date:  2010-07-27       Impact factor: 3.919

Review 6.  Spasticity treatment with botulinum toxins.

Authors:  A B Ward
Journal:  J Neural Transm (Vienna)       Date:  2008-04-04       Impact factor: 3.575

7.  Clinical evaluation of deep cerebellar stimulation for spasticity in patients with cerebral palsy.

Authors:  Marek Harat; Krzysztof Radziszewski; Marcin Rudaś; Małgorzata Okoń; Miroslav Galanda
Journal:  Neurol Neurochir Pol       Date:  2009 Jan-Feb       Impact factor: 1.621

8.  Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy.

Authors:  Chia-Lin Chang; Michael C Munin; Elizabeth R Skidmore; Christian Niyonkuru; Lynne M Huber; Douglas J Weber
Journal:  Arch Phys Med Rehabil       Date:  2009-09       Impact factor: 3.966

9.  Cortical activity in relation to velocity dependent movement resistance in the flexor muscles of the hand after stroke.

Authors:  Påvel G Lindberg; Johan Gäverth; Anders Fagergren; Peter Fransson; Hans Forssberg; Jörgen Borg
Journal:  Neurorehabil Neural Repair       Date:  2009-05-26       Impact factor: 3.919

10.  Abnormal cerebellar signaling induces dystonia in mice.

Authors:  Carolyn E Pizoli; H A Jinnah; Melvin L Billingsley; Ellen J Hess
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

View more
  4 in total

Review 1.  Central Effects of Botulinum Neurotoxin-Evidence from Human Studies.

Authors:  David Weise; Christopher M Weise; Markus Naumann
Journal:  Toxins (Basel)       Date:  2019-01-06       Impact factor: 4.546

Review 2.  The Central Effects of Botulinum Toxin in Dystonia and Spasticity.

Authors:  Pavel Hok; Tomáš Veverka; Petr Hluštík; Martin Nevrlý; Petr Kaňovský
Journal:  Toxins (Basel)       Date:  2021-02-17       Impact factor: 4.546

Review 3.  Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.

Authors:  Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2021-10-22       Impact factor: 4.546

4.  Brain functional changes in patients with botulism after illegal cosmetic injections of botulinum toxin: A resting-state fMRI study.

Authors:  Ge-Fei Li; Shiyu Ban; Mengxing Wang; Jilei Zhang; Haifeng Lu; Yan-Hui Shi; Xin-Wei He; Yi-Lan Wu; Peng Peng; Yi-Sheng Liu; Mei-Ting Zhuang; Rong Zhao; Xiao-Lei Shen; Qiang Li; Jian-Ren Liu; Xiaoxia Du
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.